Abbott Quarterly Results for Trading Insights

ABBOTINDIA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1,414 Cr
QMarch 2025
Quarterly Results

Abbott Quarterly Results Key Highlights

  • Revenue of ₹6,685 Cr in March 2025 (+0.0% vs March 2025, +9.6% vs March 2024)
  • Net Profit of ₹1,414 Cr in March 2025 (+0.0% vs March 2025, +17.7% vs March 2024)
  • EBITDA of ₹1,970 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 26.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹665.62 in March 2025 (+0.0% vs March 2025)

Abbott Quarterly Results Analysis

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 7,005 6,685 6,097 5,503 4,997 4.8% -
Net Profit (₹ Cr) 1,509 1,414 1,201 949 799 - -
EBITDA (₹ Cr) 2,103 1,970 1,701 1,360 1,165 - -
EPS (₹) 710.10 665.62 565.28 446.80 375.87 - -
Operating Margin (%) 27.0% 26.0% 25.0% 23.0% 22.0% - -

Abbott Share Price Trend Around Quarterly Results

Visualize Abbott's 1-year price movement across quarterly results — ideal for logging trades in Abbott share price chart using Tickjournal. All values in ₹.

Related Pages for Abbott

Additional stock information and data for ABBOTINDIA

ABBOTINDIA intrinsic value calculation
Abbott market worth
ABBOTINDIA share price history
ABBOTINDIA quarterly financials
ABBOTINDIA book value
ABBOTINDIA shareholding pattern
Abbott 52-week

Profitability Ratios

Profit Margin 21.2%
EBITDA Margin 29.5%
Operating Margin 26.0%
ROE (Annual) 33.4%

Balance Sheet Highlights

Total Assets ₹5,917 Cr
Total Equity ₹4,233 Cr
Current Assets ₹4,742 Cr
Current Liabilities ₹277 Cr

Cash Flow Analysis

Operating Cash Flow ₹1,012 Cr
Investing Cash Flow ₹182 Cr
Financing Cash Flow ₹-925 Cr
Net Cash Flow ₹269 Cr

Current Market Data

Current Price ₹28440.00
Exchange NSE
Last Updated Jan 06, 2026

Revenue Trend (₹ Cr)

March 2023 5,503
March 2024 6,097
March 2025 6,685
2026 7,005

Net Profit Trend (₹ Cr)

March 2023 949
March 2024 1,201
March 2025 1,414
2026 1,509

Operating Margin Trend (%)

March 2023 23.0%
March 2024 25.0%
March 2025 26.0%
2026 27.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Abbott quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹422,330.94 Cr 1760.2 14,875 3,125 +10.8% - 21.0% 135.4
Divis Laboratories
Sept 2025 		₹176,337.50 Cr 6642.5 2,860 689 +7.1% - 24.1% 255.8
Torrent Pharmaceuti…
Sept 2025 		₹136,522.12 Cr 3936.8 3,219 591 +11.3% - 18.4% 224.4
Cipla
Sept 2025 		₹121,238.47 Cr 1530.8 7,716 1,353 +12.0% - 17.5% 91.5
Dr Reddys Laborator…
Sept 2025 		₹104,829.57 Cr 1256.2 9,135 1,337 +1.1% - 14.6% 77.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores